Hugo Petit

Finanzdirektor/CFO bei ZWIPE

56 Jahre

Health Technology

Consumer Services

Process Industries

Profil

Hugo Petit currently works at Theducation AB, as Director from 2014, Falck Igel AB, as Director, Abilia Holding AG, as Director, Petit Consulting AB, as Director, Catator AB, as Director, Lipigon Pharmaceuticals AB, as Chief Financial Officer from 2023, Zwipe AS, as Chief Financial Officer & Head-Human Resource from 2024, and XNK Therapeutics AB, as Chief Financial Officer.
Mr. Petit also formerly worked at AdderaCare AB, as Chief Executive Officer, Cardiolex Medical AB, as Director, Sweden Organic AB, as Information & Expertise Director, Säljuniversitetet I Sverige AB, as Information & Expertise Director, Modina Kompetens AB, as Information Director, Modina Personal AB, as Information & Expertise Director, MedCap AB, as Chief Financial Officer from 2014 to 2018, 3 nine AB, as Head-Finance & Production, OxThera AB, as Chief Financial Officer, MedCap AB (Private Equity), as Chief Financial Officer from 2014 to 2018, Fyndiq AB, as Chief Financial Officer, and Circulose AB, as Chief Financial Officer from 2021 to 2022.
Mr. Petit received his Masters Business Admin degree from the University of Uppsala and graduate degree from Royal Military Academy.

Aktive Positionen von Hugo Petit

Unternehmen	Position	Beginn
LIPIGON PHARMACEUTICALS AB	Finanzdirektor/CFO	01.01.2023
ZWIPE	Finanzdirektor/CFO	01.02.2024
Abilia Holding AG	Direktor/Vorstandsmitglied	-
CellProtect Nordic Pharmaceuticals AB CellProtect Nordic Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops cell-based therapies for treatment of severe diseases	Geschäftsführer	-
Petit Consulting AB	Direktor/Vorstandsmitglied	-
Theducation AB Theducation AB Miscellaneous Commercial ServicesCommercial Services Provides educational and training services	Direktor/Vorstandsmitglied	01.06.2014
Falck Igel AB	Direktor/Vorstandsmitglied	-
Catator AB Catator AB Chemicals: Major DiversifiedProcess Industries Engages in catalysis and catalytic process design	Direktor/Vorstandsmitglied	-

Alle aktiven Positionen von Hugo Petit

Ehemalige bekannte Positionen von Hugo Petit

Unternehmen	Position	Ende
ADDERACARE AB	Vorstandsvorsitzender	04.01.2023
░░░░░░░░░░ ░░	░░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░ ░░ ░░░░░░░░ ░░░░░░░	░░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░ ░░	░░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░░░░ ░░░░░░░ ░░	░░░░░░░░░░░░░░░░░░░░░░░░░░	-

Sehen Sie sich die Erfahrung von Hugo Petit im Detail an

Ausbildung von Hugo Petit

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Hugo Petit im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	22
MedCap AB MedCap AB Medical SpecialtiesHealth Technology Manufactures and sells radiological & ECG equipment, probiotics and nutritional supplements	Health Technology
University of Uppsala University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Cardiolex Medical AB Cardiolex Medical AB Medical SpecialtiesHealth Technology Develops and markets the vacuum ECG for fixation of ECG electrodes	Health Technology
3 nine AB 3 nine AB Industrial MachineryProducer Manufacturing Develops solutions for the purification and processing of air	Producer Manufacturing
OxThera AB OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure	Health Services
MedCap AB (Private Equity) MedCap AB (Private Equity) Investment ManagersFinance MedCap concentrates on investments in the Nordic region as well as in Europe, with a short- or medium-term outlook. The firm targets debt-free SMEs with substantial development potential and valued up to SEK 200 million, or having SEK 50 to 200 million in turnover. They target annual returns on each investment of at least 20 percent. MedCap typically acquires majority stakes in their portfolio companies. They may also take minority stakes, with a minimum of 20 percent. Their portfolio is generally composed of eight to ten firms. They are active investors. They provide experience and access to networks along with expansion capital when necessary. Their targeted investment horizon is five to seven years. MedCap also aims to consolidate the life science market in the Nordic region. To this end, they consider merging ownership to form more robust organizations, as well as collaborating on sales, and product development. They have invested in areas such as technical aids for persons with disabilities, healthcare technologies, systems for vacuum electrodes for ECG, micro-technology and miniaturized separation science, tissue engineering to develop functional substitutes for damaged tissues, and pharmacological solutions for treatment of nicotine addiction.	Finance
Theducation AB Theducation AB Miscellaneous Commercial ServicesCommercial Services Provides educational and training services	Commercial Services
Sweden Organic AB Sweden Organic AB Food DistributorsDistribution Services Wholesales non-alcoholic and alcoholic beverages	Distribution Services
Royal Military Academy Royal Military Academy Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
CellProtect Nordic Pharmaceuticals AB CellProtect Nordic Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops cell-based therapies for treatment of severe diseases	Health Technology
Zwipe AS Zwipe AS Computer PeripheralsElectronic Technology Develops and markets biometric contactless payment cards	Electronic Technology
Fyndiq AB Fyndiq AB Specialty StoresRetail Trade Operates an online marketplace for bargain products	Retail Trade
Säljuniversitetet I Sverige AB
Catator AB Catator AB Chemicals: Major DiversifiedProcess Industries Engages in catalysis and catalytic process design	Process Industries
Falck Igel AB
Modina Kompetens AB
Modina Personal AB
AdderaCare AB AdderaCare AB Medical SpecialtiesHealth Technology Operates as holding company whose subsidiaries manufactures sensory stimulating products	Health Technology
Lipigon Pharmaceuticals AB Lipigon Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops drugs aiming at treating dyslipidemia patients	Health Technology
Abilia Holding AG
Re:NewCell AB Re:NewCell AB TextilesProcess Industries Manufactures regenerate textile fibers through used & waste clothes	Process Industries
Petit Consulting AB